ADIAL PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (ADIL) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2023 to Q4 2025

Type / Class
Equity / Common stock, par value $0.001 per share
Symbol
ADIL on Nasdaq
Shares outstanding
15,938,643
Price per share
$0.22
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
608,083
Total reported value
$214,070
% of total 13F portfolios
0%
Share change
+373,378
Value change
+$133,627
Number of holders
16
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ADIAL PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (ADIL) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
INTRACOASTAL CAPITAL, LLC 2.8% $325,786 446,282 Mitchell P. Kopin 17 Jun 2025

As of 30 Sep 2025, 16 institutional investors reported holding 608,083 shares of ADIAL PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (ADIL). This represents 3.8% of the company’s total 15,938,643 outstanding shares.

Institutional Holders of ADIAL PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (ADIL) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 27 $6 $0.22 1
2025 Q3 608,083 $214,070 +$133,627 $0.35 16
2025 Q2 234,705 $70,153 -$9,760 $0.30 16
2025 Q1 234,640 $149,046 -$82,917 $0.63 12
2024 Q4 289,676 $292,303 +$95,706 $1.01 13
2024 Q3 194,053 $193,859 -$98,515 $1.00 11
2024 Q2 283,661 $325,599 +$119,966 $1.15 13
2024 Q1 176,048 $233,389 -$211,877 $1.33 13
2023 Q4 264,302 $491,452 +$385,501 $1.86 14
2023 Q3 56,961 $158,346 +$158,346 $2.78 8